The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
Authors
Keywords
Acute myeloid leukemia, Myelodysplastic syndrome, Hedgehog pathway/Hedgehog pathway inhibition, SMO (smoothened) inhibitor, 5-azacytidine, Erismodegib
Journal
Journal of Hematology & Oncology
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-20
DOI
10.1186/s13045-015-0211-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
- (2014) Raoul Tibes et al. Journal of Hematology & Oncology
- Synergistic Targeting of AML Stem/Progenitor Cells With IAP Antagonist Birinapant and Demethylating Agents
- (2014) Bing Z. Carter et al. JNCI-Journal of the National Cancer Institute
- BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
- (2014) J M Bogenberger et al. LEUKEMIA
- Ex vivoactivity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies
- (2014) James M. Bogenberger et al. LEUKEMIA & LYMPHOMA
- Characterization of the TGF- 1 signaling abnormalities in the Gata1low mouse model of myelofibrosis
- (2013) M. Zingariello et al. BLOOD
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo
- (2013) L. Chaudhuri et al. HAEMATOLOGICA
- Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2013) Lisa Pleyer et al. Journal of Hematology & Oncology
- Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients
- (2013) Lieke H van der Helm et al. Journal of Hematology & Oncology
- Epigenetic changes: a common theme in acute myelogenous leukemogenesis
- (2013) Soraya E Gutierrez et al. Journal of Hematology & Oncology
- RNAi screening of the kinome with cytarabine in leukemias
- (2012) R. Tibes et al. BLOOD
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Activation of the hedgehog pathway in chronic myelogeneous leukemia patients
- (2011) Bing Long et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
- (2009) Chen Zhao et al. NATURE
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- 5q– myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics
- (2009) K M Eisenmann et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started